首页> 美国卫生研究院文献>Stem Cells Translational Medicine >A Facile Method to Establish Human Induced Pluripotent Stem Cells From Adult Blood Cells Under Feeder-Free and Xeno-Free Culture Conditions: A Clinically Compliant Approach
【2h】

A Facile Method to Establish Human Induced Pluripotent Stem Cells From Adult Blood Cells Under Feeder-Free and Xeno-Free Culture Conditions: A Clinically Compliant Approach

机译:在无饲养者和无异种培养条件下从成人血细胞建立人诱导多能干细胞的简便方法:一种临床顺应方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reprogramming human adult blood mononuclear cells (MNCs) cells by transient plasmid expression is becoming increasingly popular as an attractive method for generating induced pluripotent stem (iPS) cells without the genomic alteration caused by genome-inserting vectors. However, its efficiency is relatively low with adult MNCs compared with cord blood MNCs and other fetal cells and is highly variable among different adult individuals. We report highly efficient iPS cell derivation under clinically compliant conditions via three major improvements. First, we revised a combination of three EBNA1/OriP episomal vectors expressing five transgenes, which increased reprogramming efficiency by ≥10–50-fold from our previous vectors. Second, human recombinant vitronectin proteins were used as cell culture substrates, alleviating the need for feeder cells or animal-sourced proteins. Finally, we eliminated the previously critical step of manually picking individual iPS cell clones by pooling newly emerged iPS cell colonies. Pooled cultures were then purified based on the presence of the TRA-1-60 pluripotency surface antigen, resulting in the ability to rapidly expand iPS cells for subsequent applications. These new improvements permit a consistent and reliable method to generate human iPS cells with minimal clonal variations from blood MNCs, including previously difficult samples such as those from patients with paroxysmal nocturnal hemoglobinuria. In addition, this method of efficiently generating iPS cells under feeder-free and xeno-free conditions allows for the establishment of clinically compliant iPS cell lines for future therapeutic applications.
机译:通过瞬时质粒表达对人类成年血液单核细胞(MNCs)细胞进行重编程正日益流行,它是一种诱人的方法,可用于诱导诱导多能干(iPS)细胞而不会因插入基因组载体而引起基因组改变。但是,与脐带血MNC和其他胎儿细胞相比,成年MNC的效率相对较低,并且在成年个体之间差异很大。我们通过三项重大改进报告了在临床合规条件下高效iPS细胞衍生的方法。首先,我们修改了三种表达5种转基因的EBNA1 / OriP游离型载体的组合,这使重编程效率比以前的载体提高了10-50倍。其次,将人重组玻连蛋白蛋白质用作细胞培养底物,从而减少了对饲养细胞或动物来源蛋白质的需求。最后,我们通过合并新出现的iPS细胞集落,消除了手动挑选单个iPS细胞克隆的先前关键步骤。然后根据TRA-1-60多能性表面抗原的存在纯化合并的培养物,从而能够迅速扩增iPS细胞用于后续应用。这些新的改进允许一种一致且可靠的方法来产生人iPS细胞,而这些人iPS细胞的血液MNC克隆克隆最少,包括以前困难的样品,例如阵发性夜间血红蛋白尿患者的样品。另外,在无饲养者和无异种条件下有效地产生iPS细胞的这种方法允许建立用于未来治疗应用的临床顺应性iPS细胞系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号